Connect with us

Hi, what are you looking for?

Jewish Business News


Shire Licenses Teva to Sell Genereic Version of INTUNIV treatment for ADHD

logo TEVA

/By Ilan Shavit/

Pharmaceutical company Shire LLC announced on May 31st it has settled its litigation against Israeli company Teva Pharmaceutical’s US subsidiary, Teva Pharmaceuticals USA Inc., (“Teva”) in connection with Teva’s Abbreviated New Drug Application for a generic version of Shire’s INTUNIV®,   extended release tablets of the chemical substance guanfacince, for the treatment of Attention Deficit Hyperactivity Disorder – known as ADHD or sometimes just as ADD.
The settlement provides Teva with a license to market in the United States either its own generic versions of INTUNIV or authorized generic versions of  INTUNIV supplied by Shire.  The license will take effect after the expiration of a 180 day exclusivity period granted to another generic drug manufacturer Actavis, which was the first abbreviated new drug application filer for generic versions of INTUNIV.  Actavis is now licensed by Shire to market their generic product beginning onDecember 1, 2014.  
The litigation involved a patent infringement lawsuit relating to U.S. patents 6, 287, 599 (“the ‘599 Patent”), and 6, 811, 794 (“the ‘794 Patent”).  A bench trial against Actavis and Teva was held in September 2012.  As Shire has previously settled with Actavis, and has now settled with Teva, the court will not be issuing a decision on the trial.  As part of the settlement, Teva has confirmed that its proposed generic products infringe Shire’s ’599 and ’794 Patents and that the two patents are valid and enforceable with respect to those proposed generic products.
The agreements, which are effective immediately, have been submitted to the US Federal Trade Commission for its review as required by law.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.

Copyright © 2021 Jewish Business News